Francisco Carranza

The paper uses AI to analyze genomic data from colorectal cancer patients, finding TP53 pathway alterations are linked to better survival in Hispanic/Latino patients treated with FOLFOX.

This study examines WNT pathway alterations in early-onset colorectal cancer across different populations and treatment groups, finding ancestry-specific effects of FOLFOX chemotherapy on mutation frequencies and survival outcomes.

The paper identifies PI3K pathway alterations as a prognostic biomarker in early-onset colorectal cancer patients receiving FOLFOX and highlights ancestry-specific mutational differences using AI tools.

The paper uses AI to analyze genomic and clinical data from colorectal cancer patients, finding that TGF-beta pathway alterations predict poorer survival in Hispanic/Latino patients treated with FOLFOX.

This study identifies pathway-specific molecular differences in early-onset colorectal cancer (EOCRC) between Hispanic/Latino and non-Hispanic White populations, revealing distinct genetic alterations and potential ethnicity-specific survival implications.

This study compares oncogenic pathway mutations in hepatocellular carcinoma between Hispanic/Latino and Non-Hispanic White patients, identifying ethnicity-specific alterations in key pathways.

This study identifies higher PI3K and mTOR pathway alterations in early-onset CRC among Hispanic/Latino patients compared to non-Hispanic White patients, with improved outcomes linked to TP53 alterations.

This study identifies ethnicity-specific molecular alterations in MAPK and JAK/STAT pathways in early-onset colorectal cancer, showing higher MAPK mutations in Hispanic/Latino patients and potential prognostic implications.

This study compares molecular alterations in key cancer pathways between Hispanic/Latino and Non-Hispanic White gastric cancer patients, finding ethnic differences in mutation frequencies and prognostic significance.

This study identifies distinct molecular features of early-onset colorectal cancer in Hispanic/Latino patients through multi-omics analysis, revealing significant WNT pathway alterations and potential therapeutic targets.

This study profiles colorectal cancer in Hispanic/Latino patients, finding high genetic similarity to Peruvians-from-Lima-like populations and identifying key mutations and pathways associated with young-onset disease.